Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Plasmatech Biopharmaceuticals, Inc. (PTBI) Starts Presentation at LD Micro Conference

PlasmaTech Biopharmaceuticals is a biopharmaceutical company that develops protein biologic therapies and oncology supportive care products. The company’s products are MuGard, for the management of oral mucositis; and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region. It also develops CobaCyte, a mediated targeted delivery technology that has application in in tumor targeting. For more information, visit the company’s website at

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.